LDS/Medical Tests/Myelin Oligodendrocyte Glycoprotein (MOG), Antibody, Serum

Myelin Oligodendrocyte Glycoprotein (MOG), Antibody, Serum

The central nervous system is covered by myelin, synthesized by oligodendrocyte cells. Myelin oligodendrocyte glycoproteins (MOGs) are essential components of oligodendrocytes and include proteins such as myelin basic protein (MBP), phospholipid protein (PLP), and myelin-associated glycoprotein (MAG). These cell surface proteins play crucial roles in regulating oligodendrocyte functionality and maintaining and disintegrating myelin sheaths. Therefore, MOG expression serves as a marker of oligodendrocyte maturation and ongoing myelination processes.

Autoimmunity against MOG (Anti-MOG antibodies) is associated with myelination disorders and demyelination syndromes. Although some evidence suggests that anti-MOG antibodies contribute to the pathophysiology of multiple sclerosis (MS), their presence is rarely associated with MS. Several clinical trials have shown insignificant differences in anti-MOG antibody levels between MS patients and healthy controls. Instead, these antibodies are associated with the development of inflammatory demyelinating conditions distinct from MS, leading to potential misdiagnoses of MS in seropositive patients.

Patients with positive titers for anti-MOG antibodies have shown a spectrum of demyelination disorders, including optic neuritis, acute disseminated encephalomyelitis (ADEM), neuromyelitis optica, and transverse myelitis. Detecting anti-MOG antibodies using a cell-based assay has high diagnostic value for these demyelinating disorders. This assay utilizes anti-MOG antibodies in the patient’s serum to bind with MOG in MOG-expressing human embryonic kidney cells (HEK293), with bound antibodies quantified by fluorescence labeling and fluorescence-activated cell sorting (FACS). This method provides high sensitivity compared to other methods like immunohistochemistry, ELISA, or Western blot, which offer lower sensitivity. Since cerebrospinal fluid (CSF) harbors lower levels of anti-MOG antibodies, serum is preferred for testing.

  • Aids in diagnosing neuromyelitis optica and neuromyelitis optica spectrum disorder
  • Assists in diagnosing and monitoring myelin oligodendrocyte glycoprotein-related pathologies
  • Aids in diagnosing acute disseminated encephalomyelitis
A positive result indicates the presence of anti-MOG antibodies in the patient’s serum, suggesting a demyelinating disorder.

Negative

Fluorescence-activated cell sorting (FACS).

Serum (Yellow top tube).

Stability

  • Ambient: 72 hours
  • Refrigerated: 7-14 days
  • Frozen: 28 days
Aquaporin-4 IgG cell binding assay, CSF protein, ANA (Antinuclear Antibody), Folate, Vitamin B12, Treponema pallidum antibody.
3-7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login